Long-Term Safety and Efficacy of Esketamine in Patients With Treatment-Resistant Depression: A Review of Interim Results From the SUSTAIN-3 Trial

home / publications / supplement / long-term-safety-efficacy-esketamine-in-patients-treatment-resistant-depression-sustain-3-trial
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo